U.S. Representative Carolyn Maloney, in the Congressional Record (October 17, 2005), stated that "In the 1980s Barbara was essentially blacklisted from magazines by pharmaceutical companies who would not advertise in publications that carried her stories. Her relentless insistence on questioning the safety and effectiveness of their products earned her their condemnation and our praise. Barbara took advantage of this forced lull by turning to biography."
Citing Olmsted's reports, on March 30, 2006, Rep. Carolyn Maloney (NY) announced that she would be drafting legislation calling for scientific studies investigating thiomersal and autism, additional to the many already conducted.
Carolyn Jones | Carolyn Mark | Carolyn Maloney | Carolyn Forché | Carolyn Dando | Carolyn Carlson | Michael Maloney | Carolyn Meinel | Carolyn McCarthy | Carolyn Leigh | Carolyn Keene | Tim Maloney | Carolyn Talcott | Carolyn Porco | Carolyn Leckie | Carolyn Kizer | Carolyn Hester | Carolyn Hax | Carolyn De Fonseca | Carolyn Bennett | Thomas Francis Maloney | Thomas A. Maloney | Sean Patrick Maloney | Pat Maloney | Matt Maloney | Frank Maloney | Carolyn Suzanne Sapp | Carolyn Kuhl | Carolyn Jones-Young | Carolyn Griffey |
Hours after Elsevier's statement, the sponsors of the bill, Representatives Darrell Issa and Carolyn Maloney, issued a joint statement saying that they would not push the bill in Congress.
In the 111th Congress, Carolyn Maloney sponsored a bill that she claimed would have protected mutual holding company owners.
In 2011, POGO worked with Senator Patrick Leahy (D-VT) and Representative Carolyn Maloney (D-NY) to amend a defense budget bill that would have applied more secrecy to FOIA requests at the Department of Defense.